Explore
of significant morbidity and mortality. Portal hypertension remains one of the most serious sequelae of chronic liver disease. What is Portal Hypertension? Portal hypertension is a term used to describe elevated pressures in the portal venous system (a major vein that leads to the liver). Portal hypertension may be
How serious is portal hypertension?
consequence of portal hypertension: gastrointestinal bleeding resulting from ruptured gastroesophageal varices, PHG, and colopathy; hyperkinetic syndrome; hypersplenism; and an increased systemic availability of drugs and endogenous compounds with rapid hepatic uptake (5). In other complications, portal hypertension plays a key role, although it is not
What are the consequences of portal hypertension?
In this condition, splenomegaly is not only caused by portal congestion, but it is mainly due to tissue hyperplasia and fibrosis. The increase in spleen size is followed by an increase in splenic blood flow, which participates in portal hypertension actively congesting the portal system. Endothelins / biosynthesis
Why does splenomegaly occur in portal hypertension?
Uncontrolled high blood pressure can lead to complications including:
- Heart attack or stroke. ...
- Aneurysm. ...
- Heart failure. ...
- Weakened and narrowed blood vessels in your kidneys. ...
- Thickened, narrowed or torn blood vessels in the eyes. ...
- Metabolic syndrome. ...
- Trouble with memory or understanding. ...
- Dementia. ...
What are the complications associated with hypertension?
What are possible consequences to portal hypertension?
Portal hypertension is a major complication of cirrhosis, and its consequences, including ascites, esophageal varices, hepatic encephalopathy, and hepatorenal syndrome, lead to substantial morbidity and mortality.
What is the most significant consequence of portal hypertension?
The complications that most directly result from portal hypertension are the development of varices and variceal hemorrhage.
What happens if portal hypertension is left untreated?
Without treatment, portal hypertension can lead to severe complications, such as chronic bleeding, abdominal swelling, and liver failure.
Can you live a normal life with portal hypertension?
It may take a combination of a healthy lifestyle, medications, and interventions. Follow-up ultrasounds will be necessary to monitor the health of your liver and the results of a TIPSS procedure. It will be up to you to avoid alcohol and live a healthier life if you have portal hypertension.
Can you exercise with portal hypertension?
Conclusions: The present study shows that moderate exercise increases portal pressure and may therefore increase the risk of variceal bleeding in patients with esophageal varices. These findings suggest that cirrhotic patients with portal hypertension should be advised of potential risks during exercise.
What are 5 The main symptoms of portal hypertension?
What are the symptoms of portal hypertension?Enlarged liver and spleen.Enlarged veins (varices) of the esophagus and stomach. ... Internal hemorrhoids.Weight loss from malnutrition.Fluid buildup in the belly (ascites)Kidney malfunction.Low platelets.Fluid on the lungs.
What stage of liver disease is portal hypertension?
Portal hypertension is defined as the pathological increase of portal venous pressure, mainly due to chronic end-stage liver disease, leading to augmented hepatic vascular resistance and congestion of the blood in the portal venous system.
How do you fix portal hypertension?
The effects of portal hypertension can be managed through diet, medications, endoscopic therapy, surgery, or radiology. Once the bleeding episode has been stabilized, treatment options are prescribed based on the severity of the symptoms and on how well your liver is functioning.
What are 5 The main symptoms of portal hypertension?
What are the symptoms of portal hypertension?Enlarged liver and spleen.Enlarged veins (varices) of the esophagus and stomach. ... Internal hemorrhoids.Weight loss from malnutrition.Fluid buildup in the belly (ascites)Kidney malfunction.Low platelets.Fluid on the lungs.
Which of the following are clinical manifestation associated with portal hypertension?
The clinical manifestations of portal hypertension may include caput medusae, splenomegaly, edema of the legs, and gynecomastia (less commonly) (Figure 2). Caput medusae is a network of dilated veins surrounding the umbilicus.
Does portal hypertension affect the heart?
Cirrhosis with portal hypertension is associated with increased heart rate, ejection fraction and mean peak systolic velocity, while mean arterial pressure is decreased. All cardiac chamber dilation occurs and is mostly seen in the left atrium.
Does portal hypertension affect blood pressure?
Portal hypertension is an increase in the blood pressure within a system of veins called the portal venous system. Veins coming from the stomach, intestine, spleen, and pancreas merge into the portal vein, which then branches into smaller vessels and travels through the liver.
How to diagnose portal hypertension?
Portal hypertension is difficult to diagnose if symptoms aren’t obvious. Screenings such as a doppler ultrasound are helpful. An ultrasound can reveal the condition of the portal vein and how blood is flowing through it. If an ultrasound is inconclusive, a CT scan may be helpful.
What causes cirrhosis and portal hypertension?
Autoimmune diseases of the liver such as autoimmune hepatitis, primary sclerosing cholangitis, and primary biliary cholangitis also are causes of cirrhosis and portal hypertension. Whenever your liver is harmed, it attempts to heal itself. This causes scar tissue to form. Too much scarring makes it harder for your liver to do its job.
How to determine portal vein blood pressure?
Portal vein blood pressure can be determined by inserting a catheter fitted with a blood pressure monitor into a vein in your liver and taking a measurement.
How to reduce blood pressure in portal vein?
improving your diet. avoiding alcohol consumption. exercising regularly. quitting smoking if you smoke. Medications such as beta-blockers are also important to help reduce your blood pressure and relax your blood vessels. Other medications, such as propranolol and isosorbide, may help lower the pressure in the portal vein, too.
Can a blood clot form in the portal vein?
This can increase resistance to blood flow. As a result, blood pressure in the portal vein increases. A blood clot can also form in the portal vein. This can increase the pressure of blood flow against the walls of the blood vessel.
Is portal hypertension a serious condition?
Portal hypertension can be quite serious, though it’s treatable if diagnosed in time. It’s not always easy to diagnose, however. Typically, you become alerted to the condition when you start experiencing symptoms.
What is the goal of portal hypertension?
The goal of treatment for portal hypertension is to prevent further complications and decrease pressure. However, it can be difficult to maintain the proper pressure. Learn more about portal hypertension treatment at Johns Hopkins.
What is the best imaging test for portal hypertension?
They are noninvasive and can give your doctor a detailed image of your portal venous system. A duplex Doppler ultrasound is typically the first imaging test ordered. A Doppler ultrasound uses sound waves to see how the blood flows through your portal vein. The ultrasound gives your doctor a picture of the blood vessel and its surrounding organs, as well as the speed and direction of the blood flow through the portal vein.
Does Johns Hopkins have portal hypertension?
Portal Hypertension Diagnosis at Johns Hopkins. There are a number of ways to diagnose portal hypertension. For patients with end-stage liver disease who present with ascites and varices, the doctor may not need to perform any diagnostic tests and can confirm a diagnosis based on symptoms. Diagnostic procedures your doctor may order include:
Can cirrhosis cause portal hypertension?
If you have an advanced liver disease, such as cirrhosis, you have an increased risk of developing portal hypertension. Be aware of unusual symptoms and report them to your doctor right away. Symptoms and signs of portal hypertension include:
Is portal hypertension a hepatic encephalopathy?
Hepatic encephalopathy is impairment in neuropsychiatric function associated with portal hypertension. Symptoms are usually mild, with subtle changes in behavior, changes in sleep pattern, mild confusion or slurred speech. However, it can progress to more serious symptoms, including severe lethargy and coma. Although we lack clear understanding of encephalopathy, there is an association with increase in ammonia concentration in the body. (However this does not correlate to regular blood test levels of ammonia).
What happens when you have a high pressure portal?
As a result, high pressure in the portal system develops. This increased pressure in the portal vein may lead to the development of large, swollen veins (varices) within the esophagus, stomach, rectum, or umbilical area (belly button). Varices can rupture and bleed, resulting in potentially life-threatening complications.
What Causes Portal Hypertension?
The most common cause of portal hypertension is cirrhosis of the liver. Cirrhosis is scarring which accompanies the healing of liver injury caused by hepatitis, alcohol, or other less common causes of liver damage. In cirrhosis, the scar tissue blocks the flow of blood through the liver.
How Is Portal Hypertension Diagnosed?
Usually, doctors make the diagnosis of portal hypertension based on the presence of ascites or of dilated veins or varices as seen during a physical exam of the abdomen or the anus. Various lab tests, X-ray tests, and endoscopic exams may also be used.
What Lifestyle Changes Should Be Made for Portal Hypertension?
Maintaining good nutritional habits and keeping a healthy lifestyle may help you avoid portal hypertension. Some of the things you can do to improve the function of your liver include the following:
What Complications Are Associated With TIPS?
The signs of a blockage include increased ascites (accumulation of fluid in the abdomen) and re-bleeding. This condition can be treated by a radiologist who re-expands the shunt with a balloon or repeats the procedure to place a new stent.
What happens when blood vessels in the liver are blocked?
If the vessels in the liver are blocked due to liver damage, blood cannot flow properly through the liver. As a result, high pressure in the portal system develops.
Can portal hypertension be associated with liver disease?
The onset of portal hypertension may not always be associated with specific symptoms that identify what is happening in the liver. But if you have liver disease that leads to cirrhosis, the chance of developing portal hypertension is high. The main symptoms and complications of portal hypertension include: Gastrointestinal bleeding marked by black, ...
How does portal hypertension affect blood flow?
Blood from the digestive organs diverts into these collateral vessels, but portal blood flowing from the splanchnic circulation increases to compensate for the blood escaping into the collateral vessels. Increased portal blood flow exacerbates portal hypertension. Furthermore, arterial vasodilation in the splanchnic and systemic circulations observed in cirrhosis helps to increase the blood flow to the portal vein. Therefore, reducing the collateral vessel formation alone would not ameliorate portal hypertension. Inhibiting arterial vasodilation in the splanchnic circulation to reduce blood flow to portal vein together is important in the treatment of portal hypertension.2This section discusses the mechanisms of collateral vessel formation and arterial vasodilation in the splanchnic and systemic circulations in cirrhosis with portal hypertension.
What is portal hypertension?
Portal hypertension is a major complication of liver disease, which results from a variety of pathological conditions that increase the resistance to the portal blood flow into the liver. The primary cause of portal hypertension in cirrhosis is an increase in intrahepatic vascular resistance due to massive structural changes associated ...
What are the effects of LSECs?
LSECs are the first line of defense protecting the liver from injury2, and the cells exert diverse effects on liver functions including blood clearance, vascular tone, immunity, hepatocyte growth6, and angiogenesis/sinusoidal remodeling. 7, 8Therefore, LSEC dysfunction could lead to impaired vasomotor control (primarily vasoconstrictive), inflammation, fibrosis, and impaired liver regeneration1, 9, all of which facilitate the development of liver cirrhosis and portal hypertension.
How does portal pressure affect enos?
An increase in portal pressure triggers eNOS activation and subsequent NO overproduction. Changes in portal pressure are detected at different vascular beds depending on the severity of portal hypertension.41A small increase in portal pressure is sensed first by the intestinal microcirculation and increases VEGF production with a subsequent increase in eNOS levels in the intestinal microcirculation. When portal pressure further increases and reaches a certain level, vasodilation develops in the arterial splanchnic circulation (i.e., the mesenteric arteries). It is postulated that mechanical forces including cyclic strains and shear stress, which are caused by an increased blood flow associated with an increased portal pressure, activate eNOS and lead to NO production.41, 46, 52-54Subsequently, vasodilation develops in the arterial systemic circulation (i.e., the aorta).
Does intrahepatic vascular resistance reduce portal hypertension?
A reduction of intrahepatic vascular resistance could ameliorate portal hypertension.
Does reducing collateral vessel formation increase portal hypertension?
Therefore, reducing the collateral vessel formation alone would not ameliorate portal hypertension.
Is stiffness a sign of portal hypertension?
Spleen stiffness has recently received considerable attention as an indicator of portal hypertension79because it can be examined by non-invasive imaging systems such as transient elastrography80and acoustic radiation force impulse imaging.79, 81Some studies also suggest that spleen stiffness could predict the presence of varices79-81or ascites.82An experimental model of cirrhosis with portal hypertension has demonstrated that portal pressure positively correlated with the spleen size.42
What is the main complication of portal hypertension?
The main complication of portal hypertension is bleeding from the varices, and many of the treatment options aim to manage the bleeding.
What is the best treatment for portal hypertension?
Liver transplantation is the only effective treatment for cirrhosis and portal hypertension. Liver transplantation means your diseased liver is replaced with a healthy one from deceased donors or living donors who donate portions of the liver. The surgery is long and complex, requiring the removal and replacement of your body's largest solid organ. However, this option offers the highest survival rate and chance of complete rehabilitation.
How to treat variceal hemorrhage?
During an endoscopy, your doctor places small elastic rings over the vein. The rings block the blood supply to each varix. You will undergo the initial banding session and then return for subsequent sessions in order to completely obliterate the varices, which is usually achieved after four to five procedures.
What are the consequences of portal hypertension?
The most important clinical consequences of portal hypertension are related to the formation of portal-systemic collaterals; these include gastroesophageal varices, which are responsible for the main complication of portal hypertension, massive upper gastrointestinal bleeding (91).
What are the red spots on the portal?
The gastric mucosal changes associated with portal hypertension (120,121 and 122) are termed portal hypertensive gastropathy. The most frequently observed elementary lesions of PHG are the “mosaic pattern” and “cherry red spots.” The mosaic pattern, which consists of multiple erythematous areas outlined by a white reticular network, is generally considered to be “mild” PHG. Cherry red spots are round, red lesions that are slightly raised over the surrounding hyperemic mucosa. These carry a higher risk for bleeding and are considered to reflect “severe” PHG (89). They vary in severity and have been graded in the NIEC classification (89), although the clinical relevance of such grading is doubtful. The term portal hypertensive gastropathy was coined after the relationship of the lesions to portal hypertension was definitively recognized. Histologically, they are characterized by dilatation of the capillaries and venules of the gastric mucosa; mucosal inflammation and Helicobacter pylori infection are infrequent (123).
How long does it take to die from variceal bleeding?
Because it may be difficult to assess the true cause of death (i.e., bleeding vs. liver failure or other adverse events), the general consensus is that any death occurring within 6 weeks after hospital admission for variceal bleeding should be considered a bleeding-related death. Six-week mortality after variceal bleeding is about 30%. Almost 60% of deaths are caused by uncontrolled bleeding, either during the initial episode or after early rebleeding. Like the risk for rebleeding, the risk for mortality peaks during the first days after bleeding, slowly declines thereafter, and after 6 weeks becomes constant and virtually equal to that before bleeding (115,116).
What is the most widely used indicator of risk for first variceal bleeding?
The estimated size of varices at endoscopy is the most widely used indicator of risk for first variceal bleeding. Patients with medium-sized to large varices are considered to be at considerable risk for bleeding, and they should receive therapy to prevent variceal bleeding (100,110). Other clinical and hemodynamic indicators are used only in clinical research.
What is the HVPG level for esophageal varices?
Cross-sectional and prospective studies have shown that esophageal varices do not bleed below a threshold HVPG level of 11 to 12 mm Hg (1,97,99). Importantly, it has also been demonstrated in prospective studies that variceal hemorrhage does not occur if the HVPG is reduced, either spontaneously or pharmacologically, to levels below 12 mm Hg (4,97,99) or more than 20% from baseline (104). The reduction in risk for bleeding occurs despite the continued demonstration of varices in the majority of patients. However, variceal size is significantly decreased when the HVPG is reduced below threshold values (4,99).
How much does variceal bleeding occur?
The incidence of variceal bleeding is about 4% per year in nonselected patients who have never bled at the time of diagnosis (100,101). The risk is much lower (between 1% and 2%) in patients without varices at the first examination; it increases to about 5% per year in those with small varices and to 15% per year in those with medium or large varices at diagnosis (102).
Is portal hypertension a disease?
Information on the natural history and clinical manifestations of portal hypertension is primarily drawn from patients with liver cirrhosis, the best-studied disease causing portal hypertension. It is generally accepted that this information is applicable to most of the other causes of portal hypertension, although some differences may be identified in specific diseases. These differences are outlined wherever appropriate.
What are the complications of portal hypertension?
Portal hypertension is the driver of complications in cirrhosis, such as ascites and gastro-oesophageal varices (which can haemorrhage), as well as hepatic encephalopathy due to portosystemic shunting, hepatorenal syndrome and hypersplenism.5Patients with complications of portal hypertension show repeating readmissions in the hospital and are described as having unstable decompensated cirrhosis. Another area of active investigation in recent years is the mechanism of systemic inflammation, which is a cause and consequence of acute decompensation in cirrhosis, and closely associated with pre-acute-on-chronic liver failure (ACLF). Ultimately, ACLF develops with a dramatically high mortality rate of approximately 40% at 28 days.6
What is portal hypertension?
Portal hypertension, defined as increased pressure in the portal vein, develops as a consequence of increased intrahepatic vascular resistance due to the dysregulation of liver sinusoidal endothelial cells (LSECs) and hepatic stellate cells (HSCs), frequently arising from chronic liver diseases. Extrahepatic haemodynamic changes contribute to the aggravation of portal hypertension. The pathogenic complexity of portal hypertension and the unsuccessful translation of preclinical studies have impeded the development of effective therapeutics for patients with cirrhosis, while counteracting hepatic and extrahepatic mechanisms also pose a major obstacle to effective treatment. In this review article, we will discuss the following topics: i) cellular and molecular mechanisms of portal hypertension, focusing on dysregulation of LSECs, HSCs and hepatic microvascular thrombosis, as well as changes in the extrahepatic vasculature, since these are the major contributors to portal hypertension; ii) translational/clinical advances in our knowledge of portal hypertension; and iii) future directions.
Which hepatic cells are directly involved in portal hypertension?
Among the hepatic cells involved in the development of portal hypertension, LSECs and HSCs are directly involved in the increased hepatic resistance. Thus, their modulation may both relieve the pressure and in the longer run ameliorate fibrosis.
What is the consequence of thrombi formation in the liver?
What is the consequence of thrombi formation in the liver? A growing number of studies suggest the importance of intrahepatic microvascular thrombosis for fibrosis progression and portal hypertension.70This observation connecting thrombosis and liver fibrosis was first described as “parenchymal extinction” in pathological specimens of human liver cirrhosis.71Subsequently, a study in mice with CCl4-induced liver injury suggested that blood clotting is involved in the fibrotic response of the liver, given the observations of sinusoidal deposition of fibrin/fibrinogen and fibronectin in the damaged liver in the short-term, and deposition in fibrous septa during long-term liver damage.72The critical role of blood clotting in the process of fibrogenesis was also shown in a study with rats, in which administration of a thrombin antagonist (SR182289) significantly decreased CCl4-induced liver fibrosis.73Additionally, mice deficient in the prothrombinase fgl2/fibroleukin, an enzyme responsible for the conversion of prothrombin to thrombin, exhibited decreased fibrin deposition and necrosis in a model of viral hepatitis, again linking thrombosis to liver fibrogenesis.74Further, treatment with anticoagulant drugs such as nadroparin and enoxaparin (low-molecular-weight heparins) led to a decrease in liver fibrosis in rats after bile duct ligation,75,76thioacetamide administration (in which aspirin was also shown to reduce fibrosis), and CCl4-administration (in which another low-molecular-weight heparin, dalteparin, was shown to decrease fibrosis).77A mechanistic study in rat models of liver injury/fibrosis with CCl4or thioacetamide, with and without enoxaparin, demonstrated reduced portal pressure, reduced HSC activation, reduced fibrosis, and reduced fibrin deposition in enoxaparin-treated rats compared to control rats, possibly through a reduction of thrombosis.78However, enoxaparin may not be effective in the late stages of cirrhosis, as suggested by a study showing no amelioration or improvement in liver fibrosis, liver function, and portal pressure in cirrhotic rats.79Rivaroxaban, an anticoagulant drug that inhibits an active form of factor X, thereby inhibiting the generation of thrombin, has also been shown to reduce portal pressure in cirrhotic rats (induced by thioacetamide and CCl4), likely by reducing HSC activation, endothelial dysfunction, and microvascular thrombosis rather than via a direct effect on fibrosis.80Collectively, anticoagulation therapy seems beneficial for the treatment of liver fibrosis and portal hypertension, although it is dependent on the stage of cirrhosis.
Does liver stiffness increase hepatic resistance?
Stiffness:Liver stiffness may induce a mechanical increase in hepatic resistance and at least aggravate portal hypertension. The physical and chemical properties of the environment, in which HSCs are embedded, are also important for their activation,34at least partly via Src and RhoA pathways.35The majority of the fibrotic material is synthesised by HSCs, and together with other cells they contribute to the perpetuated remodelling of the matrix, reviewed elsewhere.36,37The stiffness of the matrix is provided, among other mechanisms, by the crosslinking of collagens, which leads to a less reversible fibrosis.38The stiffness itself may further boost the activation of HSCs, and the activated HSCs may migrate to those fibrosis spots due to so-called durotaxis,39which has been shown for fibroblasts,40and is likely to occur in HSCs as well. Moreover, the swelling of HSCs, e.g.in the presence of hyperammonia, may activate them and induce their contraction.41This may further lead to aggravation of fibrosis and thereby increase liver stiffness, one of the main features of clinically significant portal hypertension (CSPH) in humans.42
Is portal hypertension pathological?
It is thought that these portosystemic collateral vessels are “pathological” because they further increase portal vein inflow and increase the likelihood and the incidence of variceal haemorrhage.43,70,86Thus, numerous studies have attempted to target pathological angiogenesis in experimental models of portal hypertension and cirrhosis through a variety of approaches, such as targeting VEGF (with anti-VEGFR2 or a combination of anti-VEGF [rapamycin]/anti-PDGF [imatinib]), PlGF,51apelin,87cannabinoid,88peroxisome proliferator-activated receptor (PPAR)α and hedgehog signalling, or using sorafenib.89,90However, the reduction of collateral vessels does not always result in a decrease in portal pressure to the normal level, since this reduction does not significantly change the portal blood flow.51,91In addition, clinical studies of an anti-angiogenic approach such as anti-VEGF treatment have given unsatisfactory results because this approach also blocks the homeostatic activity of VEGF, such as wound healing angiogenesis, and other non-specific effects of VEGF that are important for vascular homeostasis. Thus, targeting only “pathological angiogenic activity” may be a novel approach to ameliorate portal hypertension.
Does increased blood inflow from the splanchnic circulation increase portal pressure?
In portal hypertension, increased portal blood inflow from the splanchnic circulation augments portal pressure and thereby contributes to the maintenance and exacerbation of portal hypertension.83Portosystemic collaterals contribute to the development of varices and the delivery of noxious substances from the portal circulation directly to the cerebral vasculature without hepatic detoxification, thus contributing to hepatic encephalopathy.84These changes together with the arterial vasodilation in the splanchnic circulation play a critical role in increasing blood flow to the portal vein.
